glp 1 medication retatrutide new glp-1 drug Treatment with retatrutide, an agonist to GLP-1, GIP, and glucagon Retatrutide: A Promising Option for
Description
But biological plausibility is not the same as clinical proof
Navigating the shortage is hard, but finding GLP-1s shouldnt be
doi: 10.1152/ajpregu.90600.2008
Separating these readouts in future trials will be essential to determine whether GLP agonism produces true reparative effects versus indirect metabolic benefits
Early research has explored whether GLP-1 agonists might enhance outcomes in autoimmune disease
The implications are significant: oral dosing removes the injection barrier that has limited uptake among the millions of patients eligible for GLP-1 therapy
